Interest in psychedelic therapy has grown significantly in recent years. In particular, topics such as psilocybin therapy and LSD-assisted therapy are increasingly discussed in relation to consciousness, self-reflection and modern scientific research. Many people are especially interested in understanding how psychedelic experiences may influence perception, thoughts and personal development1,2,3.
What is psychedelic therapy?
Psychedelic therapy refers to therapeutic or guided approaches in which consciousness-altering substances are used in controlled environments. The focus is not only on the experience itself, but also on preparation, reflection and creating a safe setting. Modern research projects are exploring how perspectives, emotions and patterns of thinking may change during these experiences1,2,3.
Why is interest in psychedelic therapy growing?
More people are becoming interested in mental wellbeing, personal development and emotional balance. At the same time, scientific interest in consciousness, neurobiological processes and reflective experiences continues to increase. Regulatory authorities and research institutions are now discussing psychedelic substances more frequently in the context of clinical trials and potential medical applications2,3,4.
- Greater awareness of mental health1,4
- Growing research into consciousness1,3
- Increased interest in personal development6,7
- More conscious reflection on thoughts and habits6,7
- New perspectives on therapeutic approaches2,3,4
Psilocybin therapy as the most well-known approach
Psilocybin therapy is currently one of the most recognised areas of psychedelic research. The combination of therapeutic guidance, a safe setting and deep self-reflection lies at the heart of this approach. Clinical studies are investigating psilocybin in relation to depression, treatment-resistant depression and psychological distress4,5.
Emotional reflection
Many people are interested in psilocybin therapy because they want to reflect more consciously on their thoughts, emotions and personal patterns. Research conducted in controlled environments often explores how perspective, mood and perception may change during these experiences4,5,6.
New perspectives on habits
Some areas of research examine how psilocybin may help people become more aware of deeply ingrained ways of thinking. Self-reflection, psychological support and post-experience integration are considered important aspects of this process1,4,5.
Magische Trüffel are also frequently associated with introspective experiences and conscious reflection. The psychoactive compound psilocybin is often studied in relation to altered perception, mystical experiences and personal meaning6,7.
LSD therapy and modern research
LSD-assisted therapy has been studied scientifically for several decades. Interest has recently increased again as researchers seek to better understand how profound experiences of perception and reflection may help people become more aware of their thoughts and emotional patterns. Professional sources describe LSD as a powerful hallucinogen that can alter perception, mood and subjective experience8,9,10.
Tiefe Selbstreflexion
Many people associate LSD-assisted therapy with intense self-reflection and shifts in perspective. Conscious engagement with thoughts and emotions often plays a central role in these experiences. Clinical studies have investigated LSD-assisted therapy in relation to anxiety disorders, among other areas8,9.
Consciousness and perception
Modern research projects are exploring how LSD may influence perception, consciousness and personal reflection. Controlled conditions, therapeutic support and safe environments remain key priorities within this research2,8,9.
Why set and setting are so important
The term “set” refers to a person’s mental state, while “setting” refers to the surrounding environment. Both factors have a significant influence on psychedelic experiences. For this reason, calmness, safety, preparation and professional guidance play an important role in therapeutic and scientific contexts2,11.
The importance of reflection and environment
Many people report that the period following a psychedelic experience is just as important as the experience itself. Reflection, conversations and intentional periods of rest often help individuals process their thoughts and impressions more effectively. This is one reason why psychedelic therapy is frequently associated with personal growth, integration and conscious self-reflection1,2,11.
Psychedelic experiences and personal development
For many people, psychedelic experiences represent more than altered perception. They can also provide new perspectives on habits, emotions and personal goals. Studies on psilocybin indicate that participants sometimes describe these experiences as personally meaningful or spiritually significant when experienced under controlled conditions6,7. As a result, some individuals become more conscious of their daily lives, mental balance and long-term personal development.
Legal status in Germany and Europe
The legal status of psychedelic substances varies considerably across Europe. Many compounds are subject to strict regulations and may not be used outside scientific or medical contexts. In Germany, many classic psychedelics, including LSD and psilocybin, are regulated under the Narcotics Act, while research and medical development are subject to specific regulatory requirements12,13,14. As a result, many people first seek information about the research, effects and legal framework surrounding these substances.
Why psychedelic therapy continues to be researched
Interest in psychedelic therapy continues to grow because researchers increasingly want to understand how consciousness, perception and emotional processes interact. The combination of self-reflection, a safe setting and personal development ensures that both psilocybin therapy and LSD-assisted therapy remain important areas of ongoing research1,2,3,4.
FAQ about psychedelic therapy
What is psychedelic therapy?
Psychedelic therapy refers to therapeutic or scientific approaches in which consciousness-altering substances are used in a controlled and supervised manner. At present, these approaches are primarily being studied within clinical research and regulated trials1,2,3.
How does psilocybin therapy work?
Psilocybin therapy takes place in controlled settings and typically combines the experience with preparation, psychological support, reflection and integration. Clinical studies are investigating psilocybin in relation to depression and treatment-resistant depression4,5.
What is LSD-assisted therapy being researched for?
Researchers are investigating how LSD may influence perception, self-reflection and emotional processes. Studies on LSD-assisted therapy have explored areas such as anxiety and psychological support in controlled environments8,9.
Why are set and setting important?
Mental state and environment strongly influence psychedelic experiences. Safety, preparation, therapeutic guidance and a controlled setting therefore play a vital role2,11.
Is psychedelic therapy legal?
The legal situation varies depending on the country. Many psychedelic substances are subject to strict regulations. In Germany, LSD and psilocybin are listed under the Narcotics Act, and research or medical use requires appropriate authorisation and regulatory approval12,13,14.
Quellen
- https://www.nature.com/articles/s44184-024-00068-9
- https://www.fda.gov/regulatory-information/search-fda-guidance-documents/psychedelic-drugs-considerations-clinical-investigations
- https://www.ema.europa.eu/en/documents/report/report-ema-multi-stakeholder-workshop-psychedelics_en.pdf
- https://doi.org/10.1056/NEJMoa2206443
- https://doi.org/10.1001/jamapsychiatry.2020.3285
- https://doi.org/10.1007/s00213-006-0457-5
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3050654/
- https://www.biologicalpsychiatryjournal.com/article/S0006-3223(22)01553-0/fulltext
- https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/lsdassisted-therapy-in-patients-with-anxiety-openlabel-prospective-12month-followup/A4EF8F8A3F7B175B5AABF3EF7DB0AA69
- https://www.euda.europa.eu/publications/drug-profiles/lsd_en
- https://doi.org/10.1007/7854_2024_509
- https://www.gesetze-im-internet.de/btmg_1981/anlage_i.html
- https://www.bfarm.de/EN/Federal-Opium-Agency/Narcotic-drugs/_node.html
- https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(24)00203-7/fulltext
